Clinical trial

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT01467375

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-01-08

PhasePHASE3

Study timeline

Study start (actual)2001-01-08Date precision: day

Registry last updated2017-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

biphasic insulin aspartDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

QuébecCanada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01467375 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.